Effectiveness of a multidimensional home nurse led heart failure disease management program - A French nationwide time-series comparison

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3652-3658

  Agrinier, Nelly ^a,b,c   Altieri, Christelle ^b   Alla, François ^a,b,c   Jay, Nicolas ^a   Dobre, Daniela ^d   Thilly, Nathalie ^a,b,c   Zannad, Faiez ^b,d  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Cost; Disease management; Heart failure; Home monitoring

Indexed keywords

ANGIOTENSIN RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; RENIN ANGIOTENSIN INHIBITOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FRANCE; HEALTH CARE COST; HEART FAILURE; HOSPITALIZATION COST; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; NURSING HOME; OBSERVATIONAL STUDY; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME SERIES ANALYSIS; VISITING NURSING SERVICE;

COST; DISEASE MANAGEMENT; HEART FAILURE; HOME-MONITORING;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEART FAILURE; HUMANS; MALE; NURSES, COMMUNITY HEALTH; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; TIME AND MOTION STUDIES; TREATMENT OUTCOME;

EID: 84886283448     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.090     Document Type: Article

References (31)

1. Article. L6113-7. 26-2-2010. Code de la santé publique.
2. Circulaire DSS/DGOS/MCGR relative aux nouvelles dispositions réglementaires du contrôle de la tarification à l'activité des établissements de santé. 2011-395, 148-157. 20-10-2011. Code de la santé publique.
3. F. Bursi, S.A. Weston, and M.M. Redfield Systolic and diastolic heart failure in the community JAMA 296 18 2006 2209 2216
4. R.A. Clark, S.C. Inglis, F.A. McAlister, J.G. Cleland, and S. Stewart Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis BMJ 334 7600 2007 942
5. F. Fagnani, L. Buteau, J.M. Virion, S. Briancon, and F. Zannad Management, cost and mortality of a cohort of patients with advanced heart failure (the EPICAL study) Therapie 56 1 2001 5 10
6. A. Gohler, J.L. Januzzi, and S.S. Worrell A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure J Card Fail 12 7 2006 554 567
7. F.M. Gomez-Soto, J.L. Andrey, and A.A. Garcia-Egido Incidence and mortality of heart failure: a community-based study Int J Cardiol 151 1 2011 40 45
8. J. Gonseth, P. Guallar-Castillon, J.R. Banegas, and F. Rodriguez-Artalejo The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports Eur Heart J 25 18 2004 1570 1595
9. R. Holland, J. Battersby, I. Harvey, E. Lenaghan, J. Smith, and L. Hay Systematic review of multidisciplinary interventions in heart failure Heart 91 7 2005 899 906
10. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479
11. S.C. Inglis, R.A. Clark, and F.A. McAlister Structured telephone support or telemonitoring programmes for patients with chronic heart failure Cochrane Database Syst Rev 8 2010 CD007228
12. Y. Juilliere, J.N. Trochu, and P. Jourdain Creation of standardized tools for therapeutic education specifically dedicated to chronic heart failure patients: the French I-CARE project Int J Cardiol 113 3 2006 355 363
13. S. Laribi, A. Aouba, and M. Nikolaou Trends in death attributed to heart failure over the past two decades in Europe Eur J Heart Fail 14 3 2012 234 239
14. L. Lindholm, and M. Rosen What is the "golden standard" for assessing population-based interventions? - problems of dilution bias J Epidemiol Community Health 54 8 2000 617 622
15. S. Mattke, M. Seid, and S. Ma Evidence for the effect of disease management: is $1 billion a year a good investment? Am J Manag Care 13 12 2007 670 676
16. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 4 2004 810 819
17. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 8 2012 803 869
18. J.J. McMurray, and M.A. Pfeffer Heart failure Lancet 365 9474 2005 1877 1889
19. N. Mitton, M. Colonna, and B. Trombert A suitable approach to estimate cancer incidence in area without cancer registry J Cancer Epidemiol 2011 2011 418968
20. A. Neumann, A. Weill, P. Ricordeau, J.P. Fagot, F. Alla, and H. Allemand Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study Diabetologia 55 7 2012 1953 1962
21. H. Patel, M. Shafazand, I. Ekman, S. Hojgard, K. Swedberg, and M. Schaufelberger Home care as an option in worsening chronic heart failure - a pilot study to evaluate feasibility, quality adjusted life years and cost-effectiveness Eur J Heart Fail 10 7 2008 675 681
22. C. Pérel, F. Chin, N. Danchin, F. Alla, Y. Juilliere, and C. De Peretti Taux de patients hospitalisés pour insuffisance cardiaque en 2008 et évolutions en 2002-2008, France Rate of patients hospitalized for heart failure in 2008 and trends between 2002 and 2008, France BEH 41 2012 466 470
23. C.O. Phillips, R.M. Singa, H.R. Rubin, and T. Jaarsma Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis Eur J Heart Fail 7 3 2005 333 341
24. S. Quach, C. Blais, and H. Quan Administrative data have high variation in validity for recording heart failure Can J Cardiol 26 8 2010 306 312
25. R. Roccaforte, C. Demers, F. Baldassarre, K.K. Teo, and S. Yusuf Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis Eur J Heart Fail 7 7 2005 1133 1144
26. S. Stewart, M.J. Carrington, and T.H. Marwick Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial J Am Coll Cardiol 60 14 2012 1239 1248
27. S. Stewart, A. Jenkins, S. Buchan, A. McGuire, S. Capewell, and J.J. McMurray The current cost of heart failure to the National Health Service in the UK Eur J Heart Fail 4 3 2002 361 371
28. A. Takeda, S.J. Taylor, R.S. Taylor, F. Khan, H. Krum, and M. Underwood Clinical service organisation for heart failure Cochrane Database Syst Rev 9 2012 CD002752
29. N. Vallier, B. Salanave, and A. Weill Les aspects économiques des affections de longue durée Actualité et dossier en santé publique 59 2007 30 37
30. C.G. Victora, J.P. Habicht, and J. Bryce Evidence-based public health: moving beyond randomized trials Am J Public Health 94 3 2004 400 405
31. D.J. Whellan, V. Hasselblad, E. Peterson, C.M. O'Connor, and K.A. Schulman Metaanalysis and review of heart failure disease management randomized controlled clinical trials Am Heart J 149 4 2005 722 729